Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results

Aims. To establish feasibility of the combination of Erlotinib and concurrent chemoradiation in pre-treated patients with locally advanced or metastatic NSCLC. Materials and Methods. Data regarding 60 consecutive patients with NSCLC previously treated with chemotherapy alone were prospectically coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramella, Sara, Alberti, Antonio Maria, Cammilluzzi, Eugenio, Fiore, Michele, Ippolito, Edy, Greco, Carlo, De Quarto, Angelo Luca, Ramponi, Sara, Apolone, Giovanni, Trodella, Lucio, Cesario, Alfredo, D'Angelillo, Rolando Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747611/
https://www.ncbi.nlm.nih.gov/pubmed/23984359
http://dx.doi.org/10.1155/2013/403869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747611/
https://www.ncbi.nlm.nih.gov/pubmed/23984359
http://dx.doi.org/10.1155/2013/403869

Ejemplares similares